Our multidisciplinary evidence synthesis teams offer expertise across RWE, HEOR, biostatistics, and access and pricing, providing the evidence you need within the most demanding of timelines and allowing you to focus on strategic interpretation.
We provide qualitative and quantitative evidence synthesis to support varying requirements, including dossier development, internal strategy support, gap analysis, modelling inputs, publication, HTA/payer/reimbursement submissions, regulatory submissions, rapid reviews, and more.